Loading provider…
Loading provider…
Rheumatology Physician in Reading, PA
NPI: 1124204136Primary Practice Location
PENN STATE HEALTH ST. JOSEPH
2500 Bernville Rd, Reading, PA
Primary Employer
PHOENIX REHABILITATION AND HEALTH SERVICES INC
HQ Phone
Get M.D. Gregory's Phone Numberphone_androidMobile
Get M.D. Gregory's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Rheumatology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 444 | 533 |
| 2 | J0897Injection, denosumab, 1 mg | 401 | 36,062 |
| 3 | 77080Bone density measurement using dedicated X-ray machine | 338 | 339 |
| 4 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 326 | 449 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 310 | 482 |
Exertion-related rhabdomyolysis observed with hyperthyroidism.
Authors: Lindner, Lauren Stone, Emkey, Gregory R
Journal: Am J Med
Publication Date: 2014-12-30
Calcium metabolism and correcting calcium deficiencies.
Secondary osteoporosis: pathophysiology & diagnosis.
Authors: Emkey, Gregory R, Epstein, Sol
Journal: Best Pract Res Clin Endocrinol Metab
Publication Date: 2014-07-18
Lead Sponsor: Radius Health, Inc.
Intervention / Treatment: COMBINATION_PRODUCT: abaloparatide, COMBINATION_PRODUCT: abaloparatide solid microstructured transdermal system
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Ixekizumab
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: TNF Inhibitor, DRUG: Baricitinib